Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- gadobenate dimeglumine
- ipodate
Interactions between your drugs
ipodate gadobenate dimeglumine
Applies to: ipodate, gadobenate dimeglumine
If you have received ipodate within the last 48 hours, you should talk to your doctor before receiving gadobenate dimeglumine. In some patients, using these medications together or within a short time of each other can cause harm to the kidneys. Contact your doctor if you experience signs and symptoms that may suggest kidney damage such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.
Radiocontrast agents
Therapeutic duplication
The recommended maximum number of medicines in the 'radiocontrast agents' category to be taken concurrently is usually one. Your list includes two medicines belonging to the 'radiocontrast agents' category:
- gadobenate dimeglumine
- ipodate
Note: In certain circumstances, the benefits of taking this combination of drugs may outweigh any risks. Always consult your healthcare provider before making changes to your medications or dosage.
Report options
- Switch to professional interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Magnevist
Magnevist (gadopentetate dimeglumine) is a contrast agent used to help diagnose certain disorders ...
Gadavist
Gadavist (gadobutrol) is a contrast agent used in MRI's to help diagnose certain disorders of the ...
Botox
Botox is used to treat chronic migraines, excessive sweating, bladder conditions, eye muscle ...
Dotarem
Dotarem (gadoterate meglumine) is a gadolinium-based contrast agent used in magnetic resonance ...
Omniscan
Omniscan is used for CNS Magnetic Resonance Imaging, vascular magnetic resonance imaging
Multihance
Multihance is used for CNS Magnetic Resonance Imaging, magnetic resonance angiography
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.